Have you ever wondered what rules Warren Buffett might use to analyze potential stock picks. In episode three, the Stig and Preston discuss Buffett’s 4 rules to selecting a successful stock pick. You won’t want to miss this important discussion! IN THIS EPISODE, YOU’LL LEARN: – Vigilant leadership – Long term prospects – Stable and
Income investors are always searching for high yields, which are hard to find with today’s historically low interest rates and record-high stock prices. But investors should not sacrifice dividend safety in favor of higher yields. This is why high-quality dividend stocks like the Dividend Aristocrats are so valuable. The Dividend Aristocrats are a select group
In this article SPCE AMZN An uncrewed New Shepard rocket launches on the company’s NS-14 test flight in January 2021. Blue Origin VAN HORN, Texas — Near a small town in the West Texas desert, a quartet led by the world’s richest person is preparing to launch on a historic flight to the edge of
In this article WFC GSBD Employees work in the cargo hold of a Boeing 737 MAX 9 test plane outside the company’s factory, on March 14, 2019 in Renton, Washington. Stephen Brashear | Getty Images News | Getty Images Check out the companies making headlines in midday trading. Delta, United, American Airlines — Airline stocks
By all measures, Clover Health (NASDAQ:CLOV) is having a rough time. Shares have lost roughly 32% of their value in the past month as retail investors on Reddit have set their sights on other targets. But is now the right time to bail on CLOV stock? If you’ve been following the mania this year, there’s
Clover Health Investments (NASDAQ:CLOV) recently reported Q1 revenue and earnings on May 17. The numbers weren’t particularly thrilling for CLOV stockholders. Source: Valeri Potapova / Shutterstock.com On May 13 I wrote that the Medicare Advantage insurer would likely report 21% higher revenue year-over-year. But I also cautioned that CLOV stock was unlikely to move much
Call it funny or call it sad, but some folks who are trading Carver Bancorp (NASDAQ:CARV) stock don’t know a thing about the company. They only know that CARV stock’s been a fast mover lately, and they want a piece of the action. Source: Pavel Kapysh/Shutterstock.com What a shame that is. Not that I can
Things have really started turning around for Express (NYSE:EXPR), the fashion-forward clothing chain that sells online and in stores. For one, EXPR stock is now up over 400% year-to-date (YTD). On Jul. 15, it closed at $4.79. Source: Helen89 / Shutterstock.com In fact, the stock is even up 68% from its recent mid-year low close of
Fisker (NYSE:FSR) stock has made big news without the company having delivered a single car to date. Of course, a lot of EV companies are making news this year. Source: Eric Broder Van Dyke / Shutterstock.com With Tesla (NASDAQ:TSLA) leading the industry, there are lots of other EV makers who are trying to take a
It’s been almost two months since AT&T (NYSE:T) announced it was spinning off WarnerMedia and merging it with Discovery (NASDAQ:DISCA, NASDAQ:DISCK), the owners of such networks as HGTV and the Food Network. Source: Jonathan Weiss/Shutterstock Right in the press release, it justified its dividend cut, which will see the quarterly payment drop by half
Americans may be optimistic people by nature, but when it comes to retirement, many of us have our doubts. In the 2021 Retirement Confidence Survey from the Employee Benefit Research Institute, only 30% of respondents said they were very confident of having enough money for a comfortable retirement. Another 40% were somewhat confident. That leaves
In this episode of The Investor’s Podcast, the Stig and Preston were asked important questions from a new value investor that’s interested in putting money into the stock market. If you’re looking to do the same, or you’re interested in hearing some fantastic questions, you won’t want to miss this week’s episode. IN THIS EPISODE,
Co-founder and director of Netflix Reed Hastings delivers a speech as he inaugurates the new offices of Netflix France, in Paris on January 17, 2020. Christophe Archambault | AFP | Getty Images As second-quarter earnings season kicks into gear, Wall Street analysts are highlighting the stocks that are poised to deliver impressive quarterly performances. The
It’s never easy to pick stocks to buy for the second half of a calendar year. That’s especially true when the markets are hotter than a pistol — which they are in 2021. As of July 14, the S&P 500 was up 18.31% year-to-date (YTD). That’s an annualized return of almost 34%. Since 1928, the
Early investors of Ocugen (NASDAQ:OCGN) stock have seen a substantial amount of return for their investment. Source: Shutterstock As early as December of last year OCGN stock has been at the $0.30 level. The stock price moved exponentially at the news that the company had signed an agreement with Bharat Biotech. The stock reached a
Imagine for a moment that you are an American investor, but as one you’re not allowed to buy into Amazon (NASDAQ:AMZN) yet Chinese investors are. Well, that’s where Chinese investors have actually been regarding Alibaba (NYSE:BABA) and BABA stock of late. Source: testing / Shutterstock.com What do I mean? This Chinese cloud company first listed on
Nassim Nicholas Taleb, New York University professor and author Jerome Favre | Bloomberg | Getty Images Nicholas Nassim Taleb has reversed his stance on bitcoin. The “Black Swan” author said in a recent paper that the largest cryptocurrency by market cap has failed to satisfy the notions of it as a currency without government, a
People walk along Wall Street in the rain on July 08, 2021 in New York City. Spencer Platt | Getty Images The bond market is defying Wall Street forecasters, as long-term Treasury yields continue to head lower despite a strong economy and rising inflation. A decline in bond yields, which move opposite price, can be
ContextLogic (NASDAQ:WISH) is a fast-growing ecommerce company that makes money from B2C commissions on products sold through its website. Last quarter its revenue grew 75% year-over-year and its gross margins grew by 53.9%. I argued in my last article that WISH stock wouldn’t move much until the company became profitable. But now I’m starting to change
Small biotech companies such as Denmark’s Orphazyme (NASDAQ:ORPH) usually have one major product, which pushes them into the spotlight. For ORPH stock, that one product is Arimoclomol. Source: Iryna Imago / Shutterstock.com Arimoclomol is a drug that could treat the rare progressive genetic disorder called Niemann-Pick Disease Type C (NPC). Investors looking for a breakthrough